WHARTEXA 25B HUC-MSCs Exosome
Whartexa 25B HUC-MSCs Exosome is a high-performance regenerative extracellular vesicle formulation developed by Nanoventra under the proprietary Whartexa Line.
​
Derived from carefully processed Wharton’s Jelly Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs), this advanced exosome system is engineered through precision extracellular vesicle isolation, controlled purification technologies, and cryopreservation methodologies intended to support elevated vesicle integrity, biological consistency, and regenerative signaling functionality.
Human-Derived Exosomes From:*
Wharton’s Jelly
Product image shown represents the finalized Whartexa formulation. Actual presentation may vary slightly depending on packaging updates, preservation configuration, and production optimization protocols.
Details
Quality
Related Products
Details
WHARTEXA 25B HUC-MSCs Exosome
Nanoventra develops advanced HUC-MSC-derived extracellular vesicle systems using controlled purification workflows, laboratory-grade isolation methodologies, and cryopreservation technologies designed to maintain extracellular vesicle integrity, biological consistency, and regenerative signaling stability.
​
Whartexa 25B is formulated from carefully processed Wharton’s Jelly umbilical biological sources and represents an advanced high-concentration formulation within the proprietary Whartexa regenerative biotechnology platform.
​
This formulation is optimized for professional regenerative integration environments requiring intensified extracellular vesicle concentration systems, precision nano-vesicle handling, advanced biological preservation support, and laboratory-oriented consistency standards.
​
Human umbilical cord-derived extracellular vesicles continue to gain importance within regenerative biotechnology, aesthetic integration science, scalp-focused applications, extracellular signaling research, and next-generation regenerative formulation development.
Key Features
-
Proprietary Whartexa regenerative exosome platform
-
Human Wharton’s Jelly HUC-MSC-derived extracellular vesicles
-
25 Billion particle concentration system
-
Advanced high-concentration regenerative formulation
-
Precision extracellular vesicle purification workflows
-
Controlled laboratory-grade isolation methodologies
-
Cryopreserved formulation maintained at −20°C
-
Enhanced vesicle stability and biological consistency
-
Professional regenerative and biotechnology-oriented integration
-
Advanced nano-vesicle handling and preservation systems
-
Research-focused extracellular vesicle preparation protocols
Quality
Specifications
All Whartexa 25B HUC-MSCs Exosome formulations undergo advanced scientific quality verification through multi-stage extracellular vesicle processing systems, controlled laboratory-oriented preparation workflows, and precision purification methodologies.
​
Each preparation is processed under sterile laboratory-grade conditions with focused attention toward:
-
extracellular vesicle integrity
-
particle concentration consistency
-
biological stability
-
purification precision
-
advanced handling reproducibility
​
Nanoventra applies biotechnology-oriented quality methodologies intended to support formulation consistency across regenerative extracellular vesicle systems and advanced exosome engineering platforms.
The Whartexa Line represents Nanoventra’s premium regenerative biotechnology division focused on advanced extracellular vesicle refinement, biological preservation technologies, and controlled exosome formulation development.
Storage & Handling
-
Recommended storage temperature: −20°C
-
Maintain cryopreserved conditions during handling
-
Avoid repeated freeze-thaw exposure
-
Professional laboratory-oriented handling recommended